Scientists have discovered a potential new way to treat one of the most aggressive blood cancers, offering hope to thousands ...

As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...

People at high risk of acute myeloid leukaemia (AML) can be identified years in advance, but there is currently no treatment ...

Karin Manchester, 65, was told she had a week to live after being diagnosed with acute myeloid leukaemia (AML), a type of blood cancer, in 2004. Thanks to successful treatment and taking part in a ...

CERo Therapeutics has announced that Colorado Blood Cancer Institute’s (CBCI) Sarah Cannon Research Institute (SCRI), US, will be the main site for its Phase I study evaluating CER-1236 to treat acute ...

Researchers hope MAGIC-I project will lead to every child and adolescent with cancer here receiving deep genome analysis to ...

New Innovative Local Treatment for Osteolytic Bone Disease ... Promising Cell Therapy Offers Hope for Relapsed or Refractory T-Cell Leukaemia Oct. 7, 2024 — Fratricide-resistant CD7 CAR-T ...

A Scots woman who received a devastating cancer diagnosis aged 17 is backing groundbreaking research into the disease. In ...

Metformin, which is mainly used to control diabetes, could help prevent an aggressive form of blood cancer, a new study ...

Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease.

On the NHS website, acute myeloid leukaemia is an aggressive form of cancer which requires immediate treatment and left untreated can be life-threatening. He underwent three rounds of chemotherapy ...

ViroCell manufactured a GMP lentiviral vector for UCL to accelerate research into prevention of relapse in childhood blood cancer UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing ...